Peter L Duffy
Overview
Explore the profile of Peter L Duffy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Box L, Blankenship J, Henry T, Messenger J, Cigarroa J, Moussa I, et al.
Catheter Cardiovasc Interv
. 2020 May;
96(4):862-870.
PMID: 32406995
The Centers for Medicare & Medicaid Services (CMS) began reimbursement for percutaneous coronary intervention (PCI) performed in ambulatory surgical centers (ASC) in January 2020. The ability to perform PCI in...
12.
Rubin G, Kirtane A, Chen S, Redfors B, Weisz G, Baber U, et al.
Catheter Cardiovasc Interv
. 2019 Nov;
96(4):793-801.
PMID: 31721430
Objectives: We sought to compare clinical outcomes after percutaneous coronary intervention (PCI) in patients on versus not on hemodialysis (HD) and examine whether high on-treatment platelet reactivity (HPR) further impacts...
13.
Redfors B, Chen S, Ben-Yehuda O, Huang X, Witzenbichler B, Weisz G, et al.
Am J Cardiol
. 2019 Sep;
124(9):1380-1388.
PMID: 31477234
Hypertension is associated with vascular and endothelial dysfunction that may result in a greater propensity for reactive platelets to cause thrombosis. We sought to assess whether the risk of major...
14.
Naidu S, Daniels M, Elmariah S, Garcia S, Klein A, Feldman D, et al.
Catheter Cardiovasc Interv
. 2019 Aug;
94(4):598-606.
PMID: 31441590
No abstract available.
15.
Blankenship J, Choi J, Das T, McElgunn P, Mukherjee D, Paxton L, et al.
Catheter Cardiovasc Interv
. 2019 May;
94(1):123-135.
PMID: 31104353
This article is intended for any physician, administrator, or cardiovascular catheterization laboratory (CCL) staff member who desires a fundamental understanding of finances and economics of CCLs in the United States....
16.
Klein L, Rab T, Anderson H, Lotfi A, Truesdell A, Duffy P, et al.
JACC Cardiovasc Interv
. 2019 Mar;
12(6):595-599.
PMID: 30898257
The responsibilities of the interventional cardiologist (IC) have evolved in contemporary practice to include substantial acute care clinical duties outside of the cardiac catheterization laboratory. In particular, the IC has...
17.
Finn M, Redfors B, Karmpaliotis D, Kirtane A, Green P, McAndrew T, et al.
Am Heart J
. 2019 Mar;
211:68-76.
PMID: 30897527
Background: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) typically requires a greater number of stents and longer stent length than non-CTO PCI, placing these patients at greater risk for...
18.
Maehara A, Mintz G, Witzenbichler B, Weisz G, Neumann F, Rinaldi M, et al.
Circ Cardiovasc Interv
. 2018 Dec;
11(11):e006243.
PMID: 30571206
Background In the large-scale ADAPT-DES study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents), drug-eluting stent implantation with intravascular ultrasound (IVUS) guidance was associated with a reduction in 1-year rates...
19.
McCabe J, Feldman D, Mahmud E, Duffy P, Box L, Marshall J, et al.
Catheter Cardiovasc Interv
. 2018 Dec;
93(3):448-450.
PMID: 30499167
No abstract available.
20.
Brener S, Kirtane A, Rinaldi M, Stuckey T, Witzenbichler B, Weisz G, et al.
Circ Cardiovasc Interv
. 2018 Oct;
11(10):e006853.
PMID: 30354629
Background: The dual antiplatelet therapy (DAPT) risk score was developed from the DAPT trial to inform the optimal duration of DAPT after percutaneous coronary intervention. We assessed the performance of...